Table 3.

Summary of the results of some studies regarding the utility of fecal calprotectin in discrimination between patients with IBD and with-out IBD.

Number of IBD patients	Age group	Location	Cut off	Sensitivity	Specificity	AUC	References
58 (CD and UC)	Adults	Taiwan	48(µg/g)	90%	95%	0.931	[58],
72 (CD and UC)	Adults	China	45 (µg/g)	94%	64%	0.949	[59],
24 (CD and UC and unclassified)	Adults	Italy	150(µg/g)	87.5%	90.5%	0.931	[51],
68(CD and UC)	Both adult and pediatric	Spain	150(µg/g)	78.5%	77%	0.872	SPS:refid::bib60,[60]
110 (CD and UC and unclassified)	pediatric	Finland	59.5(µg/g)	81.8%	96.3%	0.944	[44],
30 (CD and UC)	Adults	Iran	78.4(µg/g)	100%	100%	1.00	[47],
117 (CD and UC)	pediatric	Italy	160(µg/g)	100%	80%	0.991	[48],
44 (UC)	Adults	Iran	164(µg/g)	57%	75%	0.670	[52],
40 (CD)	Adults	Denmark	150(µg/g)	85%	81%	0.870	[45],
76 (UC)	Both adult and pediatric	India	188(µg/g)	98%	96%	0.999	[49],